AMAG Pharma (AMAG) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	305.28M
Short-term investments	308.8M
Accounts receivable, net	70.08M
Inventories	38.16M
Receivable from collaboration	0
Prepaid and other current assets	14.47M
Total current assets	736.78M
Property, plant and equipment, net	25.26M
Long-term investments
Restricted cash	2.59M
Total assets	2.53B
Accounts payable	4.74M
Accrued expenses	126.36M
Deferred revenues	34.65M
Total current liabilities	328.91M
Deferred revenues	12.51M
Other long-term liabilities
Total liabilities	1.59B
Commitments and contingencies (Notes I & J)	0
Preferred stock, par value $0.01 per share, 2,000,000 shares authorized; none issued	0
Common stock, par value $0.01 per share, 58,750,000 shares authorized; 21,182,147 and 21,137,428 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	342K
Additional paid-in capital	1.23B
Accumulated other comprehensive loss	-3.39M
Accumulated deficit	-289.59M
Total stockholders' equity
Total liabilities and stockholders' equity	2.53B

Entities mentioned with AMAG

View All Entities